Barclays’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $961K | Buy |
70,154
+25,614
| +58% | +$351K | ﹤0.01% | 2683 |
|
|
2025
Q1 | $492K | Sell |
44,540
-24,785
| -36% | -$274K | ﹤0.01% | 2856 |
|
|
2024
Q4 | $738K | Buy |
69,325
+9,547
| +16% | +$102K | ﹤0.01% | 2820 |
|
|
2024
Q3 | $759K | Buy |
59,778
+48,040
| +409% | +$610K | ﹤0.01% | 2774 |
|
|
2024
Q2 | $197K | Sell |
11,738
-7,674
| -40% | -$129K | ﹤0.01% | 3058 |
|
|
2024
Q1 | $291K | Sell |
19,412
-17,955
| -48% | -$269K | ﹤0.01% | 3145 |
|
|
2023
Q4 | $560K | Buy |
37,367
+33,946
| +992% | +$509K | ﹤0.01% | 2939 |
|
|
2023
Q3 | $48K | Sell |
3,421
-480
| -12% | -$6.74K | ﹤0.01% | 3616 |
|
|
2023
Q2 | $41K | Sell |
3,901
-4,247
| -52% | -$44.6K | ﹤0.01% | 3760 |
|
|
2023
Q1 | $75K | Sell |
8,148
-6,451
| -44% | -$59.4K | ﹤0.01% | 3665 |
|
|
2022
Q4 | $130K | Buy |
14,599
+10,817
| +286% | +$96.3K | ﹤0.01% | 3323 |
|
|
2022
Q3 | $31K | Hold |
3,782
| – | – | ﹤0.01% | 3807 |
|
|
2022
Q2 | $31K | Sell |
3,782
-3,169
| -46% | -$26K | ﹤0.01% | 3929 |
|
|
2022
Q1 | $61K | Sell |
6,951
-20,508
| -75% | -$180K | ﹤0.01% | 3921 |
|
|
2021
Q4 | $261K | Buy |
27,459
+15,699
| +133% | +$149K | ﹤0.01% | 2752 |
|
|
2021
Q3 | $198K | Buy |
11,760
+5,060
| +76% | +$85.2K | ﹤0.01% | 2985 |
|
|
2021
Q2 | $102K | Sell |
6,700
-13,368
| -67% | -$204K | ﹤0.01% | 3131 |
|
|
2021
Q1 | $392K | Buy |
20,068
+9,490
| +90% | +$185K | ﹤0.01% | 2787 |
|
|
2020
Q4 | $191K | Sell |
10,578
-2,480
| -19% | -$44.8K | ﹤0.01% | 2717 |
|
|
2020
Q3 | $252K | Sell |
13,058
-2,693
| -17% | -$52K | ﹤0.01% | 2620 |
|
|
2020
Q2 | $412K | Buy |
15,751
+5,367
| +52% | +$140K | ﹤0.01% | 2438 |
|
|
2020
Q1 | $185K | Sell |
10,384
-9,369
| -47% | -$167K | ﹤0.01% | 2579 |
|
|
2019
Q4 | $660K | Buy |
19,753
+9,799
| +98% | +$327K | ﹤0.01% | 2539 |
|
|
2019
Q3 | $237K | Sell |
9,954
-2,172
| -18% | -$51.7K | ﹤0.01% | 2991 |
|
|
2019
Q2 | $436K | Sell |
12,126
-18,437
| -60% | -$663K | ﹤0.01% | 2792 |
|
|
2019
Q1 | $1.13M | Buy |
30,563
+9,282
| +44% | +$343K | ﹤0.01% | 2067 |
|
|
2018
Q4 | $916K | Buy |
21,281
+1,281
| +6% | +$55.1K | ﹤0.01% | 1872 |
|
|
2018
Q3 | $945K | Sell |
20,000
-2,600
| -12% | -$123K | ﹤0.01% | 2287 |
|
|
2018
Q2 | $1.12M | Sell |
22,600
-2,400
| -10% | -$119K | ﹤0.01% | 1786 |
|
|
2018
Q1 | $1.24M | Buy |
+25,000
| New | +$1.24M | ﹤0.01% | 1650 |
|